Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Total Debt: 2024-2025

Historic Total Debt for Editas Medicine (EDIT) over the last 1 years, with Sep 2025 value amounting to $59.1 million.

  • Editas Medicine's Total Debt was N/A to $59.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.1 million, marking a year-over-year change of. This contributed to the annual value of $57.4 million for FY2024, which is N/A change from last year.
  • Per Editas Medicine's latest filing, its Total Debt stood at $59.1 million for Q3 2025, which was up 4.23% from $56.7 million recorded in Q2 2025.
  • Editas Medicine's 5-year Total Debt high stood at $59.1 million for Q3 2025, and its period low was $54.6 million during Q1 2025.
  • In the last 2 years, Editas Medicine's Total Debt had a median value of $57.1 million in 2024 and averaged $56.9 million.